Insmed Stock Income Statements

Insmed Quarterly Income Statements Chart

Quarterly

Annual

Revenue

Gross Profit

Operating Profit

Net Income

Insmed Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-09-30	2016-06-30	2016-03-31	2015-09-30	2015-06-30	2015-03-31	2014-09-30	2014-06-30	2014-03-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31

product revenues	107,415,000	92,823,000	104,442,000	93,425,000	90,340,000	75,500,000	83,693,000	79,072,000	77,229,000	65,214,000	59,300,000	67,730,000	65,221,000	53,107,000	56,124,000	46,757,000	45,366,000	40,214,000
yoy	18.90%	22.94%	24.79%	18.15%	16.98%	15.77%	41.13%	16.75%	18.41%	22.80%	5.66%	44.86%	43.77%	32.06%
qoq	15.72%	-11.12%	11.79%	3.41%	19.66%	-9.79%	5.84%	2.39%	18.42%	9.97%	-12.45%	3.85%	22.81%	-5.38%	20.03%	3.07%	12.81%
operating expenses:
cost of product revenues	28,075,000	21,278,000	26,151,000	21,170,000	20,964,000	17,457,000	18,443,000	16,706,000	16,594,000	13,830,000	13,069,000	13,471,000	16,395,000	12,191,000	13,288,000	10,183,000	10,837,000	9,844,000	10,862,000	10,622,000	9,950,000	8,438,000	8,706,000	6,437,000	4,919,000	4,150,000
research and development	177,190,000	152,577,000	179,727,000	150,809,000	146,748,000	121,083,000	137,029,000	109,148,000	196,969,000	127,865,000	124,763,000	99,872,000	88,527,000	84,356,000	76,352,000	70,347,000	64,655,000	61,390,000	67,814,000	41,411,000	35,748,000	36,184,000	32,630,000	34,340,000	33,538,000	31,203,000	39,925,000	39,538,000	35,722,000	30,098,000	33,949,000	26,675,000	26,871,000	22,254,000	23,433,000	23,871,000	20,547,000	19,221,000	18,246,000	17,164,000	15,200,000	14,942,000	11,351,000	12,095,000	12,225,000	10,334,000	12,228,000	5,539,000	7,527,000	4,487,000	6,518,000	6,933,000	8,706,000	5,760,000	2,453,000	769,000	893,000	642,000	724,000	1,143,000	1,472,000	5,868,000	-15,752,953	4,997,000	5,536,000	5,241,000	4,539,000	4,602,000	3,691,000	6,105,000	4,251,000	5,316,000	4,348,000	7,174,000	5,481,000	6,728,000	5,339,000	4,287,000	4,911,000	6,786,000	7,768,000	3,855,000	1,520,000	1,821,000	2,224,000	1,575,000	2,354,000	3,435,000	6,583,000	5,705,000
selling, general and administrative	154,763,000	147,545,000	142,515,000	118,930,000	106,569,000	93,102,000	89,530,000	90,626,000	84,431,000	79,914,000	73,479,000	75,583,000	59,974,000	56,748,000	65,266,000	60,280,000	57,177,000	51,550,000	56,019,000	46,585,000	49,663,000	51,346,000	50,206,000	53,347,000	52,433,000	54,810,000																												3,256,000	5,198,000	1,636,000	1,884,000	1,538,000	2,104,750	2,096,000	2,874,000	3,449,000	934,750	960,000	1,493,000	1,482,000	947,000	973,000	1,153,000	5,382,000	9,716,000	7,003,000	5,163,000	3,800,000
amortization of intangible assets	1,263,000	1,263,000	1,263,000	1,263,000	1,263,000	1,263,000	1,263,000	1,263,000	1,263,000	1,263,000	1,264,000	1,263,000	1,263,000	1,263,000	1,262,000	1,264,000	1,263,000	1,263,000	1,258,000	1,248,000	1,248,000	1,249,000	1,248,000	1,249,000	1,248,000	1,248,000
change in fair value of deferred and contingent consideration liabilities	59,000,000	18,300,000	-14,800,000	14,682,000	103,700,000	-11,900,000	15,700,000	8,997,000	13,500,000	-9,500,000	-1,800,000	5,238,000	-12,622,000	-11,618,000	-966,000	8,300,000
total operating expenses	420,291,000	340,963,000	334,856,000	306,854,000	379,244,000	221,005,000	261,965,000	226,740,000	312,757,000	213,372,000	210,775,000	195,427,000	153,537,000	142,940,000	155,202,000	150,374,000	133,932,000	124,047,000	164,963,000	89,244,000							54,904,000	83,983,000	72,882,000	62,751,000	65,353,000	44,083,000	43,515,000	35,969,000	37,149,000	36,133,000	33,067,000	30,245,000	27,952,000	26,706,000	23,404,000	22,816,000	18,079,000	16,842,000	19,769,000	14,309,000	15,838,000	9,353,000	9,983,000	7,264,000	10,273,000	35,395,000	11,451,000	9,016,000																				10,974,000	7,088,000	7,918,000	6,979,000	5,580,000	5,906,000	7,671,000	9,089,000	4,896,000	2,531,000	2,495,000	3,347,000	2,363,000	18,650,000	6,569,000	7,349,000	6,411,000
operating income	-312,876,000	-248,140,000	-230,414,000	-213,429,000	-288,904,000	-145,505,000	-178,272,000	-147,668,000	-235,528,000	-148,158,000	-151,475,000	-127,697,000	-88,316,000	-89,833,000	-99,078,000	-103,617,000	-88,566,000	-83,833,000	-94,538,000	-56,223,000	-54,114,000	-60,357,000	-47,082,000	-56,488,000	-62,166,000	-69,509,000	-87,722,000	-83,983,000	-72,882,000	-62,751,000	-65,353,000	-44,083,000															-15,838,000	-9,353,000	-9,983,000	-7,264,000	-8,870,000	-34,960,000	-10,473,000	-7,415,000	-6,330,000	-598,000	-913,000	-251,000	343,000	-764,000	-1,306,000	-6,947,000	10,658,589	-1,886,000	-4,435,000	-4,798,000	-3,344,000	-4,123,000	-2,569,000	-10,403,000	-21,404,000	-12,724,000	-9,324,000	-10,920,000	-7,064,000	-7,896,000	-6,951,000	-5,523,000	-5,883,000	-7,647,000	-9,060,000	-4,835,000	-2,504,000	-2,468,000	-3,313,000	-2,301,000	-18,624,000	-4,812,000		-6,309,000
yoy	8.30%	70.54%	29.25%	44.53%	22.66%	-1.79%	17.69%	15.64%	166.69%	64.93%	52.88%	23.24%	-0.28%	7.16%	4.80%	84.30%	63.67%	38.90%	100.79%	-0.47%	-12.95%	-13.17%	-46.33%	-32.74%	-14.70%	10.77%	34.23%	90.51%																			78.56%	-73.25%	-4.68%	-2.04%	40.13%	5746.15%	1047.10%	2854.18%	-1945.48%	-21.73%	-30.09%	-96.39%	-96.78%	-59.49%	-70.55%	44.79%	-418.74%	-54.26%	72.64%	-53.88%	-84.38%	-67.60%	-72.45%	-4.73%	203.00%	61.14%	34.14%	97.72%	20.07%	3.26%	-23.28%	14.23%	134.94%	209.85%	173.47%	110.13%	-86.55%	-48.71%		-63.53%
qoq	26.09%	7.69%	7.96%	-26.12%	98.55%	-18.38%	20.72%	-37.30%	58.97%	-2.19%	18.62%	44.59%	-1.69%	-9.33%	-4.38%	16.99%	5.65%	-11.32%	68.15%	3.90%	-10.34%	28.20%	-16.65%	-9.13%	-10.56%	-20.76%	4.45%	15.23%	16.14%	-3.98%	48.25%																69.34%	-6.31%	37.43%	-18.11%	-74.63%	233.81%	41.24%	17.14%	958.53%	-34.50%	263.75%	-173.18%	-144.90%	-41.50%	-81.20%	-165.18%	-665.14%	-57.47%	-7.57%	43.48%	-18.89%	60.49%	-75.31%	-51.40%	68.22%	36.47%	-14.62%	54.59%	-10.54%	13.60%	25.86%	-6.12%	-23.07%	-15.60%	87.38%	93.09%	1.46%	-25.51%	43.98%	-87.64%	287.03%
operating margin %	-291.28%	-267.33%	-220.61%	-228.45%	-319.80%	-192.72%	-213.01%	-186.75%	-304.97%	-227.19%	-255.44%	-188.54%	-135.41%	-169.15%	-176.53%	-221.61%	-195.23%	-208.47%
investment income	13,225,000	13,906,000	17,257,000	16,982,000	10,285,000	8,783,000	9,853,000	10,583,000	11,172,000	10,524,000	8,318,000	1,791,000	835,000	137,000	61,000	46,000	34,000	33,000	26,000	70,000	203,000	1,404,000	2,042,000	2,885,000	2,578,000	2,416,000	2,831,000	2,741,000	2,729,000	2,040,000	975,000	326,000	169,000	154,000	138,000	164,000	170,000	75,000	68,000	23,000	12,000	12,000	17,000	40,000	50,000	51,000	921,000	193,000	290,000	418,000	706,000	371,000	459,000	527,000	565,000	345,000	538,000	397,000	204,250	682,000
interest expense	-21,245,000	-21,569,000	-21,550,000	-21,054,000	-21,267,000	-21,042,000	-20,784,000	-20,288,000	-20,619,000	-20,003,000	-16,445,000	-3,353,000	-3,357,000	-3,291,000	-11,350,000	-11,245,000	-10,319,000	-7,559,000	-7,499,000	-7,185,000	-7,469,000	-7,411,000	-7,348,000	-6,846,000	-6,785,000	-6,726,000	-6,667,000	-6,675,000	-6,488,000	-5,642,000	-1,466,000	-1,496,000															-538,000	-222,000	-1,000	-2,000	-1,000	-2,000	-3,000	-4,000	-81,000			-28,000	-51,000	-68,000	-420,000	-242,000	981,744	-301,000	-328,000	-354,000	-217,000	-159,000	-155,000	-151,000	-552,000	-168,000	-164,000	-2,819,000	-6,021,000	-6,096,000	-1,825,000	-305,000
change in fair value of interest rate swap			870,000	-3,852,000	384,000	2,362,000	1,970,000	-1,301,000	1,184,000	-1,533,000
other income	453,000	132,000	-445,000	1,843,000	-269,000	-1,100,000	2,170,000	285,000	-488,000	-111,000	1,130,000	-1,514,000	-4,306,000	-1,249,000	-2,652,000	-476,000	-159,000	-43,000	419,000	-4,000	-46,000	36,000	-276,000	-85,000	-51,000	-119,000	52,000	220,000	244,000	86,000	94,000	101,000	200,000		45,000	32,000	15,000			36,000		175,000
income before income taxes	-320,443,000	-255,671,000	-234,282,000	-219,510,000	-299,771,000	-156,502,000	-185,063,000	-158,389,000	-244,279,000	-159,281,000	-159,998,000	-130,773,000	-95,144,000	-94,236,000	-113,019,000	-115,292,000	-116,699,000	-91,402,000	-101,592,000	-63,342,000	-61,426,000	-66,328,000	-52,664,000	-60,534,000	-66,424,000	-73,938,000	-91,506,000	-87,697,000	-76,397,000	-68,476,000	-65,750,000	-45,152,000															-15,455,000	-9,382,000	-9,694,000	-6,843,000	-8,164,000	-34,591,000	-10,017,000
benefit from income taxes	1,243,000	912,000	1,266,000	1,014,000	838,000	589,000	389,250	544,000	530,000	483,000			501,000	385,000			622,000	239,000	621,000	317,000	428,000	36,000	113,250	148,000	90,000	215,000	33,500	46,000	40,000	48,000	23,500	27,000	37,000	30,000	25,000	18,000	28,000
net income	-321,686,000	-256,583,000	-235,548,000	-220,524,000	-300,609,000	-157,091,000	-186,061,000	-158,933,000	-244,809,000	-159,764,000	-160,123,000	-131,145,000	-95,645,000	-94,621,000	-112,978,000	-112,714,000	-117,321,000	-91,641,000	-102,213,000	-63,659,000	-61,854,000	-66,364,000	-52,988,000	-60,682,000	-66,514,000	-74,153,000	-91,573,000	-87,743,000	-76,437,000	-68,524,000	-65,384,000	-45,179,000	-44,672,000	-37,414,000	-37,760,000	-36,579,000	-33,532,000							-17,327,000	-8,854,000	-13,678,000	-15,451,000	-9,382,000	-9,696,000	-6,845,000	-8,162,000	-34,591,000	-10,017,000	-6,894,000	-5,844,000	-330,000	-378,000	118,000	29,011,000	-150,000	-1,601,000	117,795,000	11,687,333	-2,163,000	-4,667,000	-4,873,000	-3,297,000	-3,912,000	-2,500,000	-10,253,000	-21,428,000	-12,372,000	-8,911,000	-13,427,000	-12,885,000	-13,756,000	-8,524,000	-5,764,000	-5,837,000	-7,596,000	-9,011,000	-4,759,000	-2,451,000	-2,398,000	-3,240,000	-2,209,000	-18,497,000	-4,706,000		-6,107,000
yoy	7.01%	63.33%	26.60%	38.75%	22.79%	-1.67%	16.20%	21.19%	155.96%	68.85%	41.73%	16.35%	-18.48%	3.25%	10.53%	77.06%	89.67%	38.09%	92.90%	4.91%	-7.01%	-10.50%	-42.14%	-30.84%	-12.98%	8.21%	40.05%	94.21%	71.11%	83.15%	73.16%	23.51%	33.22%											84.68%	-8.68%	99.82%	89.30%	-72.88%	-3.20%	-0.71%	39.66%	10382.12%	2550.00%	-5942.37%	-120.14%	120.00%	-76.39%	-99.90%	148.23%	-93.07%	-65.70%	-2517.30%	-454.48%	-44.71%	86.68%	-52.47%	-84.61%	-68.38%	-71.94%	-23.64%	66.30%	-10.06%	4.54%	132.95%	120.75%	81.10%	-5.40%	21.12%	138.15%	216.76%	178.12%	115.44%	-86.75%	-49.04%		-63.83%
qoq	25.37%	8.93%	6.81%	-26.64%	91.36%	-15.57%	17.07%	-35.08%	53.23%	-0.22%	22.10%	37.12%	1.08%	-16.25%	0.23%	-3.93%	28.02%	-10.34%	60.56%	2.92%	-6.80%	25.24%	-12.68%	-8.77%	-10.30%	-19.02%	4.37%	14.79%	11.55%	4.80%	44.72%	1.13%	19.40%	-0.92%	3.23%	9.09%								95.70%	-35.27%	-11.47%	64.69%	-3.24%	41.65%	-16.14%	-76.40%	245.32%	45.30%	17.97%	1670.91%	-12.70%	-420.34%	-99.59%	-19440.67%	-90.63%	-101.36%	907.89%	-640.33%	-53.65%	-4.23%	47.80%	-15.72%	56.48%	-75.62%	-52.15%	73.20%	38.84%	-33.63%	4.21%	-6.33%	61.38%	47.88%	-1.25%	-23.16%	-15.70%	89.35%	94.17%	2.21%	-25.99%	46.67%	-88.06%	293.05%
net income margin %	-299.48%	-276.42%	-225.53%	-236.04%	-332.75%	-208.07%	-222.31%	-201.00%	-316.99%	-244.98%	-270.02%	-193.63%	-146.65%	-178.17%	-201.30%	-241.06%	-258.61%	-227.88%
basic and diluted net income per share	-1.7	-1.42	-1.3	-1.27	-1.94	-1.06	-1.28	-1.11	-1.78	-1.17	-1.23	-1.09	-0.8	-0.8	-0.95	-0.96	-1.07	-0.89	-1.01	-0.63	-0.64	-0.74	-0.58	-0.68	-0.81	-0.96	-1.19	-1.14	-1	-0.89	-0.88	-0.69	-0.72	-0.6	-0.61	-0.59	-0.54	-0.5	-0.47	-0.55	-0.54	-0.59	-0.36	-0.46	-0.28	-0.43																	-0.03	-0.02	-0.04	-0.04	-0.02	-0.03	-0.02	-0.1	-0.22	-0.12	-0.09	-0.17	-0.23	-0.29	-0.19	-0.13	-0.13	-0.2	-0.23	-0.12	-0.06	-0.06	-0.1	-0.07	-0.56	-0.14		-0.19
weighted-average basic and diluted common shares outstanding	189,302	180,860	164,043	173,721	154,702	148,456	140,433	142,899	137,553	136,355	123,035	120,789	119,602	118,929	112,111	117,092	109,580	103,040	97,605	101,615	96,633	89,779	84,560	89,245	81,806	77,541	76,889	77,066	76,767	76,619	66,576	65,312	62,209	62,041	61,878	61,878	61,858	61,774	60,833	49,957	44,082	39,273	39,240	37,389	31,754	31,554	26,545	25,013,000	24,875,000	24,860,000		24,833,000
other comprehensive income:
foreign currency translation gains	2,656	1,828	205.75	2,872															79	212	-51	-37	-2	-1	-37	39	-29	2	-21	42	-37	76	5	18
unrealized loss on marketable securities	-22	-441											-491	-704
total comprehensive loss	-319,052	-255,196	-238,384	-217,147	-301,803	-157,982	-184,728	-159,760	-247,143	-159,437	-157,981	-131,602	-96,344	-95,819	-112,110	-113,038	-116,987	-91,744	-102,134	-63,447	-61,905	-66,401	-52,990	-60,683	-66,551	-74,114	-91,602	-87,741	-76,458	-68,482	-65,421	-45,103	-44,667	-37,396	-37,777	-36,564	-33,535
unrealized gain on marketable securities			-158	505		-36	99	248	-132	498	-274.75	96
foreign currency translation losses					-1,194	-855												-103
foreign currency translation loss							-862	-1,075	-2,202	-171	-313.75	-553		-494
loss on extinguishment of debt																	-17,689,000													-2,209,000
benefit for income taxes											125,000	372,000			-41,000	-2,578,000
foreign currency translation income													-208		-23.25	-324	334
revenues																			30,749,500	43,643,000	42,495,000	36,860,000	45,708,000	38,885,000	29,972,000	21,902,000																																																54,000	24,000	22,000	28,000	57,000	23,000	24,000	29,000	61,000	27,000	27,000	34,000	62,000	26,000	1,757,000	70,000	102,000
gross profit																			23,497,000	33,021,000	32,545,000	28,422,000
yoy
qoq																			-28.84%	1.46%	14.51%
gross margin %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
total costs and expenses																					86,659,000	88,779,000	69,730,500	95,373,000	92,138,000	91,411,000
costs and expenses:
general and administrative																											28,564,500	44,445,000	37,160,000	32,653,000	31,404,000	17,408,000	16,644,000	13,715,000	13,716,000	12,262,000	12,520,000	11,024,000	9,706,000	9,542,000	8,204,000	7,874,000	6,728,000	4,747,000	7,544,000	3,975,000	3,610,000	3,814,000	2,456,000	2,777,000	3,755,000	2,472,000	2,745,000																						1,607,000	1,190,000	1,640,000	1,293,000	995,000	885,000	1,321,000	1,041,000	892,000	674,000	1,123,000	788,000	911,000	601,000	766,000	706,000
other comprehensive income
other comprehensive loss:
foreign currency translation gain																																				15
cumulative translation adjustment
other (expense) / income
net income and comprehensive loss																																						-30,962,000	-28,607,000	-27,369,000	-23,990,000	-23,224,000	-14,298,000
other revenue																																													11,500,000
other
(benefit) from income taxes
gain on sale of assets																																														2,000
comprehensive loss:
unrealized gain on short-term investments, net of taxes
comprehensive loss																																												-17,327	-8,854	-13,678	-6,384,500	-9,183,000	-9,726,000	-6,629,000
unrealized gains on investments, net of taxes
license fees																																																			750,000	1,000	1,000	250,000
other expanded access program income																																																			653,000	434,000	977,000	1,351,000	1,320,000	1,806,000	1,864,000	1,927,000	1,815,500	2,454,000	2,738,000	2,070,000	1,928,250	2,998,000	2,619,000	2,292,000	2,039,000	1,424,000	1,213,000	702,000
total revenues																																																			1,403,000	435,000	978,000	1,601,000	1,321,000	1,807,000	1,864,000	1,929,000	1,971,250	2,475,000	3,040,000	2,370,000	2,210,000	4,071,000	2,648,000	2,317,000	2,142,000	1,452,000	2,275,000	1,660,000	502,000	226,000	210,000
impairment loss																																																				25,990,000
gain on sale of asset																																																		5,000									-294,000		13,000	127,755,000
income tax expense																																															1,000		2,000	2,000	500			2,000	-2,000	77,000	3,000		-3,271,000			2,794,000
accretion of beneficial conversion charge
net income attributable to common stockholders																																															-15,451,000	-9,382,000	-9,696,000	-6,845,000	-8,162,000	-34,591,000	-10,017,000	-16,069,000
basic and diluted net income attributable to common stockholders per common share																																															-260	-380	-390	-280	-665	-1,390
less: accretion of beneficial conversion feature																																																			-2,293,750			-9,175,000
see accompanying notes to unaudited consolidated financial statements
basic and diluted net income attributable to common
stockholders per common share																																																					-400
weighted-average basic common shares outstanding																																																			23,348,000		24,830,000	18,814,000
weighted-average diluted common shares outstanding																																																			23,348,000		24,830,000	18,814,000
income before taxes																																																						-6,892,000	-5,846,000	-253,000	-375,000	118,000	29,709,500	-150,000	-1,601,000	120,589,000
basic and diluted net income attributable to common stockholders
per common share																																																						-850
royalties																																																							1,000	1,000		2,000	19,750	21,000	30,000	28,000	20,750	29,000	29,000	25,000	41,000	28,000	17,000	35,000	50,000	24,000	30,000
grant revenue																																																											136,000		272,000	272,000	261,000	1,044,000
total expenses																																																							7,651,000	2,405,000	2,777,000	2,180,000	4,225,500	3,239,000	4,346,000	9,317,000	4,878,250	5,957,000	7,083,000	7,115,000	5,486,000	5,575,000	4,844,000	12,063,000	21,906,000	12,950,000	9,534,000
basic net income per share																																																							-0.49	0	0	0	0.01	0	-0.01	0.96
shares used in computing basic net income per share																																																							-117,003	130,301	130,249	130,208
diluted net income per share																																																							-0.49	0	0	0	0.01	0	-0.01	0.96
shares used in computing diluted net income per share																																																							-117,003	130,301	130,249	130,551
realized loss on investments																																																																		392,000
shares used in computing basic net profit per share																																																											31,518	129,442	126,178	122,522
shares used in computing diluted net profit per share																																																											31,564	129,442	126,178	122,698
interest income																																																													112,000	23,000	-452,500	78,000	96,000	279,000	264,000	370,000	224,000	301,000	528,000	520,000	577,000	312,000	200,000	236,000	252,000	64,000	46,000	51,000	49,000	76,000	53,000	70,000	73,000	92,000	127,000	106,000	172,000	202,000
sales																																																																						423,000	452,000	202,000	180,000
license income																																																																			62,000		1,045,000	500,000
cost of goods sold																																																																						576,000	836,000	631,000	23,000
loss on investments																																																															499,500	-54,000	54,000
shares used in computing basic and diluted net income per share																																																															30,517.5	122,314	121,989	121,904	2,403	121,708	113,577	101,328	1,790	100,231	100,152	79,987	2,804	47,799	44,998	44,986	761	38,406	38,395	38,395	938	37,583	33,162	33,211	25	33,139	33,034	32,948
operational restructuring
operational restructuring charge																																																																																								2,533,000
non-cash stock compensation
see accompanying notes.

We provide you with 20 years income statements for Insmed stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Insmed stock. Explore the full financial landscape of Insmed stock with our expertly curated income statements.

The information provided in this report about Insmed stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.